A Dose Escalation Study of Trientine Plus Carboplatin and Pegylated Liposomal Doxorubicin in Women With a First Relapse of Epithelial Ovarian, Tubal, and Peritoneal Cancer Within 12 Months After Platinum-Based Chemotherapy-Reference-Cited by-同舟云学术

A Dose Escalation Study of Trientine Plus Carboplatin and Pegylated Liposomal Doxorubicin in Women With a First Relapse of Epithelial Ovarian, Tubal, and Peritoneal Cancer Within 12 Months After Platinum-Based Chemotherapy

Published:2019-05-24 Issue: Volume:9 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Huang Yu-Fang,Kuo Macus Tien,Liu Yi-Sheng,Cheng Ya-Min,Wu Pei-Ying,Chou Cheng-Yang

Funder

National Science Council

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference38 articles.

1. HowladerN NooneAM KrapchoM MillerD BishopK KosaryCL YuM RuhlJ TatalovichZ MariottoA LewisDR ChenHS FeuerEJ CroninKA Bethesda, MDNational Cancer InstituteSEER Cancer Statistics Review, 1975–2014

2. Cancer statistics, 2018;Siegel;CA Cancer J Clin,2018

3. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods;Ferlay;Int J Cancer,2018

4. Novel strategies for reversing platinum resistance;Shahzad;Drug Resist Updat,2009

5. Overcoming platinum resistance in ovarian carcinoma;Matsuo;Expert Opin Investig Drugs,2010

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling Cuproptosis: Mechanistic insights, roles, and leading advances in oncology;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-11

2. Mechanisms associated with cuproptosis and implications for ovarian cancer;Journal of Inorganic Biochemistry;2024-08

3. Targeting cuproplasia and cuproptosis in cancer;Nature Reviews Clinical Oncology;2024-03-14

4. Copper metabolism and cuproptosis in human malignancies: Unraveling the complex interplay for therapeutic insights;Heliyon;2024-03

5. Copper in Gynecological Diseases;International Journal of Molecular Sciences;2023-12-17